Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. Cortex
  4. Retinal Implants

Retinal Implants

Microelectrode arrays that restore partial vision by stimulating surviving retinal cells
Back to CortexView interactive version

Next-generation retinal implants are vision prostheses that use high-density microelectrode arrays placed either epiretinally (on the surface of the retina) or subretinally (beneath the retina) to stimulate surviving retinal cells in people with retinal degenerative diseases, paired with smart glasses that capture visual information from the environment and process it into stimulation patterns. Companies like Pixium Vision and Second Sight are developing these systems to provide pattern vision for patients with conditions like retinitis pigmentosa, where the photoreceptor cells die but other retinal cells remain functional, enabling the restoration of some visual function by directly stimulating the retina to create phosphene patterns that the brain can interpret as vision.

This innovation addresses vision loss from retinal degenerative diseases, where the photoreceptors (light-sensing cells) are lost but other parts of the visual system remain functional. By stimulating surviving retinal cells, these implants can restore some vision. The technology is being developed for conditions like retinitis pigmentosa and age-related macular degeneration.

The technology is particularly significant for people with retinal degenerative diseases, where restoring vision could dramatically improve quality of life. As the technology improves, it could provide better vision restoration. However, achieving high resolution, creating natural visual perception, and managing long-term stability remain challenges. The technology represents an important approach to vision restoration, but requires continued development to achieve the resolution and quality needed for practical use. Success could restore vision for people with retinal diseases, but the technology must overcome challenges in creating high-quality visual perception and maintaining long-term functionality. The field has faced challenges, with some companies like Second Sight discontinuing products, highlighting the difficulty of creating effective vision prostheses.

TRL
7/9Operational
Impact
5/5
Investment
4/5
Category
Applications

Related Organizations

Palanker Lab (Stanford University)

United States · University

95%

The research lab responsible for inventing the photovoltaic retinal prosthesis technology licensed to Pixium Vision and Science Corp.

Researcher
Science Corp logo
Science Corp

United States · Startup

95%

Developing the Science Eye, a visual prosthesis combining gene therapy and a micro-LED display implant.

Developer

Bionic Vision Technologies

Australia · Consortium

90%

An Australian consortium commercializing a suprachoroidal retinal implant.

Developer
Institut de la Vision

France · Research Lab

90%

One of Europe's largest research centers dedicated to vision diseases, heavily involved in the clinical validation of the Prima implant.

Researcher

Nano Retina

Israel · Startup

90%

Developer of the NR600, a miniature artificial retina designed to be implanted with a minimally invasive procedure.

Developer
LambdaVision logo
LambdaVision

United States · Startup

85%

Developing protein-based artificial retinas manufactured in microgravity to improve layering quality.

Developer
NIDEK

Japan · Company

85%

A major ophthalmic equipment manufacturer involved in the research and development of artificial retina systems (STS) in Japan.

Developer
iBionics

Canada · Startup

80%

Developing the 'Diamond Eye', a wireless retinal implant that aims to provide higher resolution vision.

Developer

Supporting Evidence

Evidence data is not available for this technology yet.

Connections

Applications
Applications
Visual Neuroprostheses

Neural implants that restore vision by stimulating the retina or visual cortex

TRL
5/9
Impact
5/5
Investment
4/5
Applications
Applications
Cochlear Implant Advances

AI-powered cochlear implants with fully internalized hardware for natural hearing restoration

TRL
8/9
Impact
5/5
Investment
5/5
Applications
Applications
Advanced Restorative Neuroprosthetics

Prosthetic limbs that respond to thought and transmit touch, pressure, and temperature back to the user

TRL
6/9
Impact
5/5
Investment
5/5
Hardware
Hardware
Bidirectional Peripheral Interfaces

Neural cuffs that read motor commands and deliver sensory feedback through peripheral nerves

TRL
5/9
Impact
5/5
Investment
4/5
Hardware
Hardware
High-Density Cortical Arrays

Electrode arrays recording thousands of neurons simultaneously for brain–machine interfaces

TRL
6/9
Impact
5/5
Investment
5/5
Hardware
Hardware
Endovascular Neural Interfaces

Stent-based electrodes implanted through blood vessels to record brain activity without open-skull surgery

TRL
7/9
Impact
5/5
Investment
5/5

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions